Personal Homepage

Personal Information:

MORE+

Degree:Doctoral Degree in Medicine
Status:Employed
School/Department:药学院

Login      SDU     

Yingjie Zhang

+

Gender:Male

Education Level:Postgraduate (Doctoral)

Alma Mater:山东大学

Paper Publications

Current position: Home / Scientific Research / Paper Publications
Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Date of Publication:2017-06-01 Hits:

Affiliation of Author(s):药学院
Journal:Anti-cancer agents in medicinal chemistry
All the Authors:xuwenfang,Yingjie Zhang
First Author:高帅
Indexed by:Unit Twenty Basic Research
Document Code:D23360BF099544ED984837D788DD749A
Volume: 17
Issue:6
Page Number:802
Translation or Not:no
Date of Publication:2017-06-01
Date of Publication:2017-06-01

Pre One:Discovery of a fluorescent probe with HDAC6 selective inhibition

Next One:Nitric oxide donor hybrid compounds as promising anticancer agents

  • Click:
  • MOBILE Version

The Last Update Time:..

Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100
Information desk: (86) - 0531-88395114
On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University